• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国大唾液腺癌发病率的上升。

The rising incidence of major salivary gland cancer in the United States.

作者信息

Del Signore Anthony G, Megwalu Uchechukwu C

机构信息

Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Ear Nose Throat J. 2017 Mar;96(3):E13-E16. doi: 10.1177/014556131709600319.

DOI:10.1177/014556131709600319
PMID:28346649
Abstract

We performed a population-based historical cohort study using the Surveillance, Epidemiology, and End Results (SEER) database to determine trends in the incidence of major salivary gland cancer and to evaluate the effect of sex, tumor size, histology, primary site, and extent of disease. Participants were men and women with major salivary gland cancer, diagnosed 1973-2009. The incidence of major salivary gland cancer increased from 10.4 per 1,000,000 in 1973 to 16 per 1,000,000 in 2009 (annual percent change [APC] 0.99; 95% confidence interval [CI] 0.78 to 1.20; p < 0.05). The incidence of parotid cancers increased (APC 1.13; 95% CI 0.88 to 1.39; p < 0.05) and paralleled the increase in major salivary gland cancer overall. There was an increase in the incidence of tumors measuring 0 to 2.0 cm (APC 1.99; 95% CI 0.61 to 3.38; p < 0.05), but no change in tumors measuring 2.1 to 4.0 cm (APC 1.02; 95% CI -0.46 to 2.52; p > 0.05) and tumors measuring > 4 cm (APC -0.52; 95% CI -1.72 to 0.69; p > 0.05). There was an increase in the incidence of regional (APC 0.77; 95% CI 0.32 to 1.23; p < 0.05) and distant (APC 2.43; 95% CI 1.43 to 3.45; p < 0.05) disease, but not localized disease (APC 0.35; 95% CI 0 to 0.71; p > 0.05). We conclude that the incidence of major salivary gland cancer is increasing, especially small parotid tumors. The incidence of tumors with regional and distant metastasis is also increasing. These findings highlight the need for further research on the etiology of salivary gland cancer, which may reveal opportunities for further public health efforts aimed at prevention.

摘要

我们利用监测、流行病学和最终结果(SEER)数据库开展了一项基于人群的历史性队列研究,以确定大唾液腺癌的发病率趋势,并评估性别、肿瘤大小、组织学类型、原发部位和疾病范围的影响。研究对象为1973年至2009年间诊断为大唾液腺癌的男性和女性。大唾液腺癌的发病率从1973年的每100万人中10.4例增至2009年的每100万人中16例(年百分比变化[APC]为0.99;95%置信区间[CI]为0.78至1.20;p<0.05)。腮腺癌的发病率有所上升(APC为1.13;95%CI为0.88至1.39;p<0.05),且与大唾液腺癌总体发病率的上升趋势一致。大小为0至2.0厘米的肿瘤发病率上升(APC为1.99;95%CI为0.61至3.38;p<0.05),但大小为2.1至4.0厘米的肿瘤发病率无变化(APC为1.02;95%CI为-0.46至2.52;p>0.05),大小大于4厘米的肿瘤发病率下降(APC为-0.52;95%CI为-1.72至0.69;p>0.05)。局部区域(APC为0.77;95%CI为0.32至1.23;p<0.05)和远处(APC为2.43;95%CI为1.43至3.45;p<0.05)疾病的发病率上升,但局限性疾病发病率未上升(APC为0.35;95%CI为0至0.71;p>0.05)。我们得出结论,大唾液腺癌的发病率正在上升,尤其是小的腮腺肿瘤。伴有局部区域和远处转移的肿瘤发病率也在上升。这些发现凸显了对唾液腺癌病因进行进一步研究的必要性,这可能会揭示开展更多旨在预防的公共卫生工作的机会。

相似文献

1
The rising incidence of major salivary gland cancer in the United States.美国大唾液腺癌发病率的上升。
Ear Nose Throat J. 2017 Mar;96(3):E13-E16. doi: 10.1177/014556131709600319.
2
Second primaries after major salivary gland cancer.大涎腺癌后的第二原发癌。
Otolaryngol Head Neck Surg. 2011 Aug;145(2):254-8. doi: 10.1177/0194599811402899.
3
The Impact of Demographic and Socioeconomic Factors on Major Salivary Gland Cancer Survival.人口统计学和社会经济因素对大唾液腺癌生存率的影响。
Otolaryngol Head Neck Surg. 2014 Jun;150(6):991-8. doi: 10.1177/0194599814526556. Epub 2014 Mar 19.
4
Increased risk of salivary gland cancer among women with a previous cancer diagnosis.既往有癌症诊断史的女性患唾液腺癌的风险增加。
Head Neck. 2016 Apr;38 Suppl 1:E446-51. doi: 10.1002/hed.24016. Epub 2015 Jul 14.
5
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.1988 - 2005年美国分化型甲状腺癌发病率上升
Cancer. 2009 Aug 15;115(16):3801-7. doi: 10.1002/cncr.24416.
6
Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018.美国甲状腺癌发病率和死亡率趋势:2000-2018 年。
Thyroid. 2022 May;32(5):560-570. doi: 10.1089/thy.2021.0662. Epub 2022 Mar 15.
7
Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.2004 - 2009年美国垂体肿瘤的描述性流行病学
J Neurosurg. 2014 Sep;121(3):527-35. doi: 10.3171/2014.5.JNS131819. Epub 2014 Jun 13.
8
Clinical characteristics and outcomes of major salivary gland malignancies in children.儿童大唾液腺恶性肿瘤的临床特征与转归
Laryngoscope. 2018 May;128(5):1126-1132. doi: 10.1002/lary.26946. Epub 2017 Oct 9.
9
Mobile phone use and trends in the incidence of cancers of the parotid and other salivary glands.手机使用与腮腺和其他唾液腺癌症发病率的变化趋势。
Cancer Epidemiol. 2021 Aug;73:101961. doi: 10.1016/j.canep.2021.101961. Epub 2021 May 18.
10
Salivary Carcinosarcoma: An Extremely Rare and Highly Aggressive Malignancy.唾液腺癌肉瘤:一种极其罕见且极具侵袭性的恶性肿瘤。
Laryngoscope. 2020 May;130(5):E335-E339. doi: 10.1002/lary.28183. Epub 2019 Jul 10.

引用本文的文献

1
Targeting the cancer glycocalyx in salivary duct carcinoma: tumor-associated mucin 1 (Tn-MUC1) as a novel cell surface marker.靶向唾液腺导管癌中的癌症糖萼:肿瘤相关粘蛋白1(Tn-MUC1)作为一种新型细胞表面标志物。
J Pathol Clin Res. 2025 Sep;11(5):e70042. doi: 10.1002/2056-4538.70042.
2
An epidemiological trend analysis of oral cancer in Korea from 2001 to 2021.2001年至2021年韩国口腔癌的流行病学趋势分析。
BMC Oral Health. 2025 Jul 1;25(1):969. doi: 10.1186/s12903-025-06351-1.
3
Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions.
唾液腺癌靶向治疗和全身治疗的进展:当前选择与未来方向
Curr Oncol. 2025 Apr 16;32(4):232. doi: 10.3390/curroncol32040232.
4
Clinical Outcomes of Intensity Modulated Proton Therapy for Salivary Gland Carcinoma: High Local Control and Quality of Life Preservation.调强质子治疗涎腺癌的临床结果:高局部控制率及生活质量保留
Head Neck. 2025 Aug;47(8):2313-2323. doi: 10.1002/hed.28149. Epub 2025 Mar 31.
5
The imaging presentation of head and neck oncologic emergencies.头颈部肿瘤急症的影像学表现。
J Clin Imaging Sci. 2025 Feb 4;15:7. doi: 10.25259/JCIS_35_2023. eCollection 2025.
6
Trends in the Age-Adjusted Incidence of Head and Neck Cancer in South Korea Over the Past 20 Years.过去20年韩国头颈癌年龄调整发病率的趋势
Clin Exp Otorhinolaryngol. 2025 May;18(2):180-187. doi: 10.21053/ceo.2024.00346. Epub 2025 Jan 24.
7
Prognostic Implications of Occult Nodal Metastases in Patients with Clinically N0 Primary Parotid Gland Cancer.临床N0期原发性腮腺癌患者隐匿性淋巴结转移的预后意义
Medicina (Kaunas). 2024 Nov 25;60(12):1942. doi: 10.3390/medicina60121942.
8
The impact of digital inequities on salivary gland cancer disparities in the United States.数字不平等对美国唾液腺癌差异的影响。
Head Neck. 2025 Feb;47(2):538-548. doi: 10.1002/hed.27930. Epub 2024 Sep 25.
9
Nomogram based on immune-inflammatory indicators and age-adjusted charlson comorbidity index score to predict prognosis of postoperative parotid gland carcinoma patients.基于免疫炎症指标和年龄调整 Charlson 共病指数评分的列线图预测腮腺癌患者术后预后。
BMC Oral Health. 2024 Jun 22;24(1):718. doi: 10.1186/s12903-024-04490-5.
10
Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland.转移性皮肤鳞状细胞癌几乎占腮腺鳞状细胞癌的全部。
Virchows Arch. 2024 Jul;485(1):3-11. doi: 10.1007/s00428-024-03798-5. Epub 2024 Apr 17.